So you received the AstraZeneca COVID-19 vaccine now what? - Action News
Home WebMail Saturday, November 23, 2024, 04:59 PM | Calgary | -11.6°C | Regions Advertise Login | Our platform is in maintenance mode. Some URLs may not be available. |
Windsor

So you received the AstraZeneca COVID-19 vaccine now what?

The government of Ontario abruptly halted use of the AstraZeneca-Oxford COVID-19 on Tuesday, saying that no more first doses of the product would be administered effective immediately due to concerns over arare but serious side effect.

Medical officer of health for Windsor-Essex weighs in on vaccine's pause in Ontario

Vials of the AstraZeneca's COVID-19 vaccine are seen in a file photo. Ontario is pausing use of the product as of Tuesday. (Leonhard Foeger/Reuters)

Ontario has paused use of the AstraZeneca-Oxford COVID-19 vaccine, saying that effective Tuesday, no more first doses of the product willbe administered due to concerns over arare but serious side effect.

Since March, the vaccine has been givento thousands of people in Windsor-Essex.

And if you're one of them, here'swhat you need to know about the change in guidance, and what comes next:

Why is Ontario pausinguse of the vaccine?

Dr. David Williams, the province's chief medical officer of health, said the province made the decisiondue to anincrease in cases of arare blood clotting syndromeknown as Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) linked tothe AstraZeneca vaccine.

"Effective today, Ontario will be pausing the rollout and administration of first doses of the AstraZeneca vaccine at this time," Williams told reporters on Tuesday.

Williams said the decision was made out of an abundance of caution. The blood clotting syndrome, while rare, can be fatal.

According to the Ontario health ministry, as of May 8, more than853,000doses of the AstraZeneca vaccine wereadministered with a rate of VITT of roughly oneper 100,000 doses administered.

The ministry said there have been increased reports of VITT, with a rate of 1.7 per 100,000 doses administered, over the last few days.

Has anyone inWindsor-Essex experiencedVITT?

Dr. Wajid Ahmed, medical officer of health for Windsor and Essex County, saidWednesday he isn't aware of any local cases of VITT.

The vaccine was offered at dozens of pharmacies in the region starting in March, and according to the Windsor-Essex County Health Unit (WECHU),37,071 doses have been administered.Most recently, the vaccine was available to those 40 and up.

"I think they made the right choice bygetting the first vaccine available to them," Ahmedsaid.

He said that many medications have side effects, and some of those risks are much higher than what has beenseenwith the AstraZeneca product. He noted that the vaccine was the primary one used across theU.K.

I had an AstraZenecashot. What about my2nd dose?

So far, there's no guidance on what happens next for those who received the vaccine and still need the required second dose within four months. The province is reviewing data to consider whether to use the vaccine to provide those doses.

There's apossibility, however, that those who previously received the vaccine might be eligible for adifferent product for their second dose.

Windsor-Essex medical officer of health Dr. Wajid Ahmed said Wednesday he is not aware of anyone in the region experiencing a rare blood clotting syndrome known as Vaccine-Induced Immune Thrombotic Thrombocytopenia linked to the AstraZeneca vaccine. (Jennifer La Grassa/CBC)

Ahmed said that research is being done on the topic and he anticipates that the National Advisory Council on Immunization will come forward with recommendations by the end of the month.

A fewAstraZeneca vaccinerecipients in Windsor who were approached byCBC News on Wednesday indicated that they would be OK with either option.

Chris Boak said despite being a little concerned about getting a different product for the second dose, he would do that or takeanother AstraZeneca dose if it was an option.

"I'm going to look into getting eitherPfizer or the other shot for my second second and go from there," he said.

Gillian Merritt, who has received the vaccine along with her husband Ted, also said she would take the second doseifwas offered, as well as useanother vaccine.

WATCH | Ontario's health minister says thegovernment is awaiting guidance on what's next:

Ontario defers decision on vaccines after AstraZeneca pause

3 years ago
Duration 1:30
Ontario's Health Minister Christine Elliott says the province is awaiting guidance from health regulators and advisory committees before it makes two key decisions: what to do with AstraZeneca vaccines after first doses were paused and if two different COVID-19 vaccines can be mixed.

She's hoping there's clarity on the issue by the time she is due for her second dose.

"Hopefully by the end of June we'll know if we can mix or match or we can have the second AstraZenecashot," she said.

If there's no adverse reaction after the first shot, thechance of oneoccurring after the second shot is very low, according to Ahmed.

Is this a setback for the local vaccine rollout?

Because of the small supply of the AstraZeneca vaccine currently in Windsor-Essex, themedical officer of health said he doesn't think that the decision will slow down the overall vaccine distribution effort.

Ahmed said the pharmacies with remaining supply will receive guidance from the ministry of health either to store their supply or send it back.

Currently, 54.4 per cent of adults in Windsor-Essex have gotten at least one shot of a COVID-19 vaccine. That puts the local rollouta little ahead of Ontario'srate, which the province announced Wednesday has surpassed 50 per cent.

With files from Muriel Draaisma and Jennifer La Grassa

Add some good to your morning and evening.

Your daily guide to the coronavirus outbreak. Get the latest news, tips on prevention and your coronavirus questions answered every evening.

...

The next issue of the Coronavirus Brief will soon be in your inbox.

Discover all CBC newsletters in theSubscription Centre.opens new window

This site is protected by reCAPTCHA and the Google Privacy Policy and Google Terms of Service apply.